IBD Cutting Edge 2026: Where Innovation, Trials, and Multidisciplinary Care Intersect

Scripps Health, in collaboration with UC San Diego, presents IBD Cutting Edge 2026. This conference will showcase pioneering advancements in translational science, drug discovery, and clinical care for inflammatory bowel disease (IBD). The program will highlight the evolving landscape of clinical trials, innovative therapeutic strategies, and the complexities of managing IBD in diverse patient groups. Key topics will cover disease-specific complications, care considerations for special populations, the role of surgery in IBD management, and the integration of multidisciplinary approaches to enhance treatment outcomes.

Additionally, the conference will introduce emerging technologies, patient-centered care initiatives, and discussions on ensuring equity in access to care. Attendees will benefit from lectures and interactive sessions led by both international and national key opinion leaders in IBD. The comprehensive program will provide health care professionals with actionable insights to optimize patient care, advance clinical practices, and improve the quality of life for those living with IBD.

NEW THIS YEAR! An engaging hands-on Intestinal Ultrasound Workshop will be offered on Friday as a complement to the main conference. This immersive workshop will offer a unique opportunity to learn and refine ultrasound techniques for assessing inflammatory bowel disease (IBD) under the guidance of world-renowned experts. Gain practical skills in utilizing this non-invasive, real-time imaging modality to enhance diagnosis, monitor disease activity, and optimize patient care. Whether you're a beginner or looking to advance your expertise, this workshop is designed to elevate your clinical practice and keep you at the cutting edge of IBD management.

1. Explore Translational Science: Describe how emerging insights from translational research are shaping novel therapeutic approaches for inflammatory bowel disease (IBD).
2. Analyze Clinical Trial Innovations: Evaluate findings from recent and ongoing clinical trials to inform the development and application of next-generation therapies for IBD.
3. Integrate Multidisciplinary Care Strategies: Identify opportunities to optimize patient outcomes through collaborative care models involving gastroenterologists, surgeons, dietitians, psychologists, and other specialists.
4. Implement Advanced Surgical and Medical Approaches: Assess the latest advancements in surgical interventions and medical therapies, including their roles in treating complex IBD cases.
5. Address Challenges in Special Populations: Examine the unique treatment considerations for pediatric, adolescent, and high-risk IBD populations, ensuring equitable and personalized care.
6. Foster Patient-Centered Care: Develop approaches that emphasize shared decision-making and improved quality of life for patients living with IBD.

*Must use a valid Scripps email address when registering.

**To receive the student, resident, fellow registration discount code, please email or call Scripps CME and provide proof of your status.

Scripps Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Scripps Health designates this activity for a maximum of 19.00 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Maintenance of Certification

American Board of Internal Medicine
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 10.25 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

American Board of Pathology
Successful completion of this CME activity enables the learner to earn 10.25 Lifelong Learning (CME) credit toward the CME requirement(s) of the American Board of Pathology’s Continuing Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABP credit.

Attendee Cancellation, Substitution and Refund
The course tuition is refundable, minus a $100 processing fee (MD, DO, RN, PA, NP) or a $50 processing fee (Student, Resident, Fellow), if your cancellation is received in writing no later than Friday, August 28, 2026. Attendee substitutions are allowed, but notification must be made in writing by Friday, August 28, 2026. After this date, under no circumstances will refunds, credits, or substitutions be granted. No refunds or credits will be given to “no shows.” No refunds shall be made for cancellations due to inclement weather. Pre-conference workshop registration fees will be refunded in full until August 28, 2026.

Scripps Course Modification or Cancellation
Scripps reserves the right to modify the course’s schedule or program as necessary. Scripps also reserves the right to cancel this course, in which case a full refund of the registration fee will be provided. Attendees who purchase non-refundable airline tickets do so at their own risk. Scripps encourages the purchase of travel insurance as we are unable to refund any travel costs (flight, hotel, etc.) in the case of Scripps cancellation.

Recording and Photography Clause
Scripps reserves exclusive rights to record (audio and video) and/or photograph all course proceedings for use in marketing materials, presentations and course content sales.

Family and Guest Attendance Policy
All course activities and meals are exclusively reserved for paid course attendees. Children and family members are not allowed to attend meal functions or permitted in the meeting space.

Accessibility Statement
Scripps is committed to ensuring that its programs, services, goods and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Amendments Act of 2008. If you have needs that require special accommodation, including dietary concerns, please email [email protected].

Hyatt Regency Mission Bay
1441 Quivira Rd
San Diego, California 92109
Reservations: 619-224-1234
Reserve a Discounted Room

Please make your own hotel reservations and request the Scripps conference reduced rate of $269 per night (plus tax and parking). A block of rooms is being held for us until Friday, August 21, 2026, or until the room block fills, whichever comes first. After this date, reservations will be accepted on a space and rate availability basis only. Attendees who book their room through an online, third-party service are not eligible for room block concessions including discounted resort fee and discounted overnight self-parking.

TRAVEL ADVISORY
Please reserve your room using the link provided above or by contacting the hotel directly. If you receive an email from an organization claiming to be a third-party booking site and urging you to book rooms for the course through their service or link, avoid clicking any links in these emails or sharing any personal information with them. These emails are phishing attempts, and the organizations behind them are not associated with Scripps or the course hotel.

Mitigation of Relevant Financial Relationships

Disclosure of Relevant Financial Relationships and Content Validity

It is policy at Scripps Health’s Office of Continuing Medical Education (CME) for course directors, planners, moderators, faculty, and all others in a position to control content of an educational activity disclose all financial relationships with ineligible companies that they may have had within the past 24 months. This policy is in accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education. An ineligible company is any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. If an individual refuses to disclose financial relationships, they will be disqualified from being a part of the planning and implementation of the activity. Owners and/or employees of an ineligible company with business lines or products relating to the content of the activity will not be permitted to participate in the planning or execution of any accredited program.

The intent of this policy is to ensure that Scripps Health CME/CE certified activities promote quality and safety, are effective in improving medical practice, consist of valid, evidence-based content, and are independent of control from ineligible companies and free of commercial bias. Peer review of all content was conducted for all faculty presentations whose disclosure information was found to contain any financial relationships. This process consisted of reviewing the content, determining which financial relationships were relevant, and applying appropriate mitigation strategies. All listed relevant financial relationships with ineligible companies for individuals in control of content have been mitigated prior to the commencement of the activity.

The staff in Scripps Health’s Office of Continuing Medical Education have disclosed that they have no financial relationships with any ineligible companies. Any peer reviewer who is determined to have a relevant financial relationship must recuse themselves from the peer review process.

Member Information

Role in activity

Nature of Relationship(s) / Name of Ineligible Company(s)

Shannon Kennedy
Scripps Health
San Diego, CA

Activity Coordinator

Nothing to disclose

Megan Wray
Scripps Health
San Diego, CA

Activity Coordinator

Mazer R Ally, MD FACP FACG, FAGA, FACG, FCCF
Scripps Clinic
Oceanside, CA

Co-Director, Faculty

Speakers Bureau-AbbVie (Any division)|Speakers Bureau-Takeda Pharmaceuticals (Any division)|Speakers Bureau-Janssen (Any division)

Gauree Gupta G Konijeti, MD MPH
Scripps Clinic
La Jolla, CA

Co-Director, Faculty

Advisor-AbbVie (Any division)|Advisor-Johnson & Johnson|Advisor-Cristcot

Amy Lightner, MD
Scripps Clinic, Scripps Research Institute
La Jolla, CA

Co-Director, Faculty

Bincy Abraham, MD MS
Houston Methodist
Houston, TX

Faculty

Consulting Fee-AbbVie (Any division)|Consulting Fee-Boehringer Ingelheim Pharmaceuticals, Inc.|Consulting Fee-Johnson & Johnson|Consulting Fee-Lilly (Any division)|Grant or research support-Lilly (Any division)|Consulting Fee-Pfizer (Any division)|Consulting Fee-Takeda Pharmaceuticals (Any division)|Consulting Fee-Sanofi S.A.|Consulting Fee-Roche (Any division)

Jana Al Hashash, MD MS
Mayo Clinic
Jacksonville,

Faculty

Lori A Beeken, MS RDN
Scripps Health
La Jolla, CA

Faculty

Abha Bosworth, MPH MS PA-C
University of California San Diego
La Jolla, CA

Faculty

Mallory Chavannes, MD
Children's Hospital Los Angeles
Los Angeles, CA

Faculty

Aaron J Dawes, MD, PhD, FACS, FASCRS
Stanford Medicine
Palo Alto, CA

Faculty

Paid consultant-Intuitive Surgical, Inc.

Anthony de Buck, MD MSc
Cleveland Clinic
Moreland Hills, OH

Faculty

Speakers Bureau-Takeda Pharmaceuticals (Any division) (Relationship has ended)|Speakers Bureau-AbbVie (Any division) (Relationship has ended)|Speakers Bureau-Johnson & Johnson (Relationship has ended)

Andre D'Hoore, MD PhD
IBD Leuven
Leuven, Belgium

Faculty

Samuel Eisenstein, MD
University of California San Diego
La Jolla,

Faculty

Adam S Faye, MD, Director of Clinical Research, NYU IBD Center
NYU Langone Health
New York, NY

Faculty

Consulting Fee-Merck (Any division) (Relationship has ended)|Consulting Fee-Lilly (Any division) (Relationship has ended)|Honoraria-Takeda Pharmaceuticals (Any division) (Relationship has ended)

Phillip Fleshner, MD
Cedars-Sinai
Los Angeles, CA

Faculty

Phillip Gu, MD
Cedars-Sinai
Los Angeles,

Faculty

Christina Ha , MD FAC AGAF
Mayo Clinic
Phoenix, AZ

Faculty

Sara Horst, MD MPH
Vanderbilt Health
Nashville, TN

Faculty

Consulting Fee-AbbVie (Any division) (Relationship has ended)|Consulting Fee-Takeda Pharmaceuticals (Any division) (Relationship has ended)|Consulting Fee-Pfizer (Any division) (Relationship has ended)|Consulting Fee|Consulting Fee|Consulting Fee-Janssen (Any division) (Relationship has ended)

Jeannie Huang, MD MPH
Rady Children's Health
San Diego,

Faculty

Melissa Kirkpatrick, PharmD
University of California San Diego
La Jolla, CA

Faculty

Paulo Gustavo Kotze, MD MSc PhD
Catholic University
Curitiba, Brazil

Faculty

James Marion, MD
Mount Sinai
New York, NY

Faculty

Kerri Novak, MD
University of Calgary
Calgary,

Faculty

Nimisha K Parekh, MD, FACG, AGAF
University of California Irvine
Irvine, CA

Faculty

Advisor-Cristocot (Relationship has ended)|Advisor-Celltrion (Relationship has ended)

Shintaro Sagami, MD PhD
Kitasato University Kitasato Institute Hospital
Minato,

Faculty

Shayle Savoie, MSN, MSN, RN
Scripps Health
Vista, CA

Faculty

Nothing to disclose

Preetika Sinh, MD
University of California San Diego
San Diego, CA

Faculty

Advisor-Criscot|Advisor-Celltrion

Teddy Solomon, FNP, COCN-AP
Cedars-Sinai
Los Angeles, CA

Faculty

Matthew Tsai, MD PhD, Physician
University of California San Diego
La Jolla, CA

Faculty

Nothing to disclose

Valery Vilchez Parra, MD
University of California Irvine
Irvine,

Faculty

Bonnie Zagorski, RN BSN
Scripps Health
La Jolla, CA

Faculty

Brigid S Boland, MD
University of California San Diego
La Jolla, CA

Faculty, Planning Committee Member

Grant or research support-Merck (Any division)|Consulting Fee-SRT Therapeutics|Consulting Fee-criscot (Relationship has ended)|Consulting Fee-Sanofi S.A.|Consulting Fee-Janssen (Any division)|Consulting Fee-celltrion|Grant or research support-SRT Therapeutics|Grant or research support-Gilead Sciences, Inc. (Relationship has ended)|Grant or research support-mirador

Angelina Collins, MSN ANP-BC
University of California San Diego
La Jolla, CA

Faculty, Planning Committee Member

Melissa J. J Ferrari, MPAS PAC
Scripps Clinic
La Jolla, CA

Faculty, Planning Committee Member

Please download and review the support prospectus for details on what is and what is not included with the various support options:

IBD Cutting Edge 2026 Exhibit & Support Prospectus